The in-vitro toxicology testing market size was valued at USD 9.1 billion in 2020 and is anticipated to expand at significant CAGR during forecast period 2021–2028. Growth of the market is attributed to increasing population, increased global illicit drug abusers, advancement in genetics, and enhanced efficiency of in-vitro toxicology testing in diagnosis of cancer.
In-vitro toxicity testing is the scientific method of finding the effects of toxic chemical compounds on mammalian cells and cultured bacteria. In-vitro testing done in a laboratory generally contains animal cells, micro-organism, and human cells in culture. This system of analysis allows scientists to asses’ different biological singularities in specific cells without the interruptions and potential confusing.
The Covid-19 pandemic affected the demand and supply of in-vitro toxicology testing market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
- Rapid advancement in genetics is projected to boost the market in the coming years.
- Increasing awareness about environmental concerns is the major factor fueling the market in coming years.
- Decrease in adaptation rate of in-vitro toxicology testing is anticipated to restrict the market growth.
- Incapability of in-vitro toxicology testing to detect toxicity is projected to hamper the market expansion.
- R&D investment and technological advancement in in-vitro toxicology testing is projected to create lucrative opportunities for the market players.
Scope of the Report
The report on the in-vitro toxicology testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
In-vitro Toxicology Testing Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018-2019
|
|
Forecast Period
|
2021-2028
|
|
Segmentation
|
Technologies [Cell Culture, Molecular Imaging, High throughput, and OMICS], Types [Toxic Substances, Dose, and Absorption], Applications [Cytotoxicity, Neuro Toxicity, and Dermal Toxicity], End-users [Food Industry, Cosmetic and Household Products, Chemical Industry, Pharmaceuticals Industry, and Others]
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East &
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players covered in the Report
|
Agilent Technologies, Inc., BioReliance, Inc., Abbott Laboratories, Covance, Inc., Eurofins Scientific, Agilent Technologies, Bio-Rad Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., Accelrys, Inc., MatTek Corporation, Catalent, Inc., Xenometrix AG, Quest Diagnostics Incorporation, and Charles River Laboratories International, Inc.
|
Market Segment Insights
The cosmetic and household products accounts for key share of the market
Based on end-users, the in-vitro toxicology testing market is segregated into food industry, cosmetic and household products, chemical industry, pharmaceuticals industry, and others. The cosmetic and household products segment is projected to expand at a rapid pace during the forecast period. Growth of the market is attributed to the increasing population, advancement in genetics, and enhanced efficiency of in-vitro toxicology testing in diagnosis of cancer. However, the pharmaceuticals industry segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing R&D procedures, ban on animal testing, and stringent government regulations towards environment.
The cell culture segment accounts for a significant share of the market
On the basis of technologies, the in-vitro toxicology testing market is segmented into cell culture, molecular imaging, high throughput, and OMICS. The cell culture segment accounts for a key share of the market. Growth of the market is attributed to rising population, ban on animal testing, and stringent government regulations towards environment.
The toxic substances segment is anticipated to grow at rapid peace
Based on types, the in-vitro toxicology testing market is divided into toxic substances, dose, and absorption. The toxic substances segment accounts for a key share of the market. Growth of the market is attributed to increasing demand of in-vitro toxicology testing in pharmaceuticals sector and increasing advancement in genetics. The absorption segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increased global illicit drug abusers and rapid technological advancement in in-vitro toxicology testing method.
The neuro toxicity segment is expected to expand at a rapid pace during the forecast period
On the basis of applications, the in-vitro toxicology testing market is segmented into cytotoxicity, neuro toxicity, and dermal toxicity. The neuro toxicity segment holds the major market share. Neuro toxicity is obtained when the body exposes to human made and natural toxic compounds. This compound changes the general activity of the nervous system. The dermal toxicity is the capacity of a compound to cause systemic poisoning and general reaction in animals and human, when it comes in contact with the skin.
The market in North America is projected to dominate the market
On the basis of regions, the in-vitro toxicology testing market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is projected to dominate the market due to increase in number of R&D procedures, ban on animal testing, and stringent government regulations towards environment. The market in Asia Pacific is anticipated to expand at high CAGR during forecast period due to factors increased global illicit drug abusers and rapid technological advancement in in-vitro toxicology testing method.
Segments
Segments Covered in the Report
The in-vitro toxicology testing market has been segmented on the basis of
Technologies
- Cell Culture
- Molecular Imaging
- High throughput
- OMICS
Types
- Toxic Substances
- Dose
- Absorption
Applications
- Cytotoxicity
- Neuro Toxicity
- Dermal Toxicity
End-users
- Food Industry
- Cosmetic and Household Products
- Chemical Industry
- Pharmaceuticals Industry
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Agilent Technologies, Inc.
- BioReliance, Inc.
- Abbott Laboratories
- Covance, Inc.
- Eurofins Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Alere, Inc.
- Thermo Fisher Scientific, Inc.
- Accelrys, Inc.
- MatTek Corporation
- Catalent, Inc.
- Xenometrix AG
- Quest Diagnostics Incorporation
- Charles River Laboratories International, Inc.
Competitive Landscape
Key players competing in the in-vitro toxicology testing market include Agilent Technologies, Inc., BioReliance, Inc., Abbott Laboratories, Covance, Inc., Eurofins Scientific, Agilent Technologies, Bio-Rad Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc., Accelrys, Inc., MatTek Corporation, Catalent, Inc., Xenometrix AG, Quest Diagnostics Incorporation, and Charles River Laboratories International, Inc.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming year.
Request For Customization
Enquiry Before Buying
Speak With Analyst
